Weight regain risk calculator for after a GLP-1
In trials, people who stopped a GLP-1 regained about 60% of the weight they had lost within a year, levelling off near 75%. Real-world results are often much better: in one 7,938-person cohort, average regain at a year was 0.5% of body weight.
Enter your weights and stop date to see the published average regain curve for your numbers, the real-world range, and the factors that raise or lower your risk. Educational, not a prediction.
By Ian MacCallum, Founder · GLP-Done. Last reviewed . Read our methodology and editorial policy.
An average, not a prediction. The curve is the published average from trials where people stopped with no drug. It does not diagnose or predict your outcome. Regain after a GLP-1 is physiology, not failure, and its degree is reducible.
Leave blank for today.
Example: 210 to 175 lb on semaglutide, stopped 8 weeks ago
Solid line: trial average of 35 lb lost. Dashed: real-world cohort average at 1 year. Shaded: the first 26 weeks, the steepest part of the curve.
| After stopping | Trial average | Share of loss |
|---|---|---|
| 3 months | 8.6 lb | 24% |
| 6 months | 14 lb | 41% |
| 12 months | 21 lb | 60% |
| Real world, 1 year | 0.9 lb | 0.5% of body weight |
Where you are
Week 8 of 13
First 90 days, the high-risk window
Hold-the-line weight
179 lb
A check-in trigger, not a target: if your weekly average crosses it, revisit the pillars and talk to your clinician.
Build the missing pillars
How much weight do people regain after stopping a GLP-1?
| Study | What happened | Timeframe |
|---|---|---|
| Regain trajectory meta-regression (6 trials) | Regain followed a curve that levels off near 75% of the weight lost; about 60% had returned by one year, similar across liraglutide, semaglutide and tirzepatide | About 60 weeks to plateau |
| STEP 1 extension (semaglutide) | People regained about two thirds of the weight they had lost, but stayed about 5.6% below their starting weight | 1 year after stopping |
| SURMOUNT-4 (tirzepatide) | 89.5% of people who stayed on the drug kept at least 80% of their loss, vs 16.6% of those switched to placebo | 52 weeks |
| Cleveland Clinic real-world cohort (7,938 people) | People with obesity regained an average of 0.5% of body weight; 45% stayed stable or kept losing | 1 year |
Why trials and real life look so different
Trials stop everyone at once and follow them without the drug. In real life, many people restart or switch medications (about 20% restarted and 27% switched in the Cleveland Clinic cohort), had smaller losses to begin with, or stopped for cost rather than by plan. That is why the calculator shows both lines: the trial curve is the clearest picture of the biology, and the real-world line shows that many people do much better.
What raises weight regain risk
| Factor | Evidence | What helps |
|---|---|---|
| The first 3 to 6 months off | Strong: the curve is steepest here | A plan for the first 90 days |
| A larger amount lost | Moderate: regain scales with the size of the loss | Earlier, more frequent check-ins |
| Low protein and muscle loss | Moderate | A protein target |
| No resistance training | Moderate | Strength training |
| Short or irregular sleep | Moderate | Sleep routine |
| Dropping self-monitoring | Strong | Weekly weigh-ins |
| Stopping abruptly | Limited: tapering is barely studied | Organize a taper with your prescriber |
What lowers it
The same habits, in place before appetite returns: protein at most meals (protein targets), lifting 2 to 3 times a week (strength training), 7 to 9 hours of sleep (sleep), small routines that run on autopilot (habit stacking) and a weekly weigh-in (hold the line). The maintenance calorie calculator gives the intake line to watch.
Worked example
Someone went from 210 to 175 lb on semaglutide (35 lb lost) and stopped 8 weeks ago. The trial average projects about 14 lb back by 6 months and about 21 lb by 12 months. The real-world reference is about 1 lb. Their hold-the-line weight is 175 lb plus 2%, about 179 lb: if the weekly average crosses it, that is the cue to revisit the pillars and check in with their clinician.
Your first 26 weeks off the pen
| When | What tends to happen |
|---|---|
| Weeks 1 to 4 | The drug clears and appetite starts to return (see the clearance timeline) |
| Weeks 5 to 13 | The steepest part of the regain curve; routines matter most |
| Weeks 14 to 26 | The curve slows; weekly trends tell you whether the plan is working |
| After 26 weeks | Regain tends to level off; keep the check-ins |
Read the first 90 days off the pen and why weight comes back after a GLP-1.
Questions about this tool
What is the risk of regaining weight after Ozempic or Wegovy?
In the STEP 1 extension, people who stopped semaglutide regained about two thirds of the weight they had lost within a year. Real-world results vary widely, and many people regain much less.
How fast does weight come back after stopping Zepbound or Mounjaro?
Across trials, regain is fastest in the first 3 to 6 months and slows after that. The pooled curve was similar for tirzepatide, semaglutide and liraglutide.
Will I regain all of it?
Not on average. The published curve levels off near 75% of the weight lost, and real-world cohorts often show far less.
What predicts weight regain?
The early months off, a larger loss, low protein and muscle loss, no resistance training, poor sleep, and dropping self-monitoring are all linked to more regain.
Does tapering reduce regain?
The evidence is limited: tapering has barely been studied, though one real-world study saw less regain. Whether and how to taper is your clinician's call.
Does restarting or switching change the picture?
Yes. Many real-world patients restart or switch medications, which is one reason real-world regain looks smaller than in trials. Talk to your clinician about your options.
Is regain my fault?
No. Regain after a GLP-1 is physiology: the drug quiets appetite and that effect fades when it stops. The degree is reducible with habits, but it is not a personal failure.
Does this calculator predict my outcome?
No. It applies a published trial average to your numbers for orientation. Your own trend over the coming weeks is what matters, and your clinician is the right person to interpret it.
Read more
- Maintenance
Why Weight Comes Back After GLP-1: Physiology, Not Failure
- Maintenance
The First 90 Days Off the Pen: A Week-by-Week Guide
- Maintenance
A 6-Month Maintenance Plan for After GLP-1
- Maintenance
Weight Regain After Wegovy: What to Expect and How to Respond
- Maintenance
How to Keep Weight Off After Stopping a GLP-1
Sources & further reading
Every claim on this page is drawn from peer-reviewed research, clinical trials, or recognized health authorities. Read the source before making any decision about your health.
- [1]Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regressionNIH/PMC
- [2]Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extensionNIH/PMC
- [3]Rebound or Retention: A Meta-Analysis of Weight Regain After Discontinuation of GLP-1 Receptor AgonistsNIH/PMC
- [4]Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight LossNIH/PMC
- [5]Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical TrialNIH/PMC
- [6]What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic StudyCleveland Clinic
- [7]Impact of Protein Intake During Weight Loss on Preservation of Fat-Free Mass, Resting Energy Expenditure, and Physical FunctionNIH/PMC
- [8]Resistance training as a key strategy for high-quality weight loss in men and womenNIH/PMC
- [9]Sleep Deprivation: Effects on Weight Loss and Weight Loss MaintenanceNIH/PMC
- [10]Characterizing Self-Monitoring Behavior and Its Association With Physical Activity and Weight-Loss MaintenanceNIH/PMC